NEOCAP Trademark

Trademark Overview

On Wednesday, July 16, 2025, a trademark application was filed for NEOCAP with the United States Patent and Trademark Office. The USPTO has given the NEOCAP trademark a serial number of 99286978. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 16, 2025. This trademark is owned by Nephrogen Inc.. The NEOCAP trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations containing viral vectors for drug delivery consisting of compounds comprised of proteins in the form of capsids that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of viral capsids, viral and non viral vectors, and biodegradeable protein capsids that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of kidney disease and genetic diseases disease

Development of pharmaceutical preparations and medicines; Research and development services in the field of pharmaceutical preparations; Development of new technology for others in the field of viral vector-based gene therapy and genomic medicines to treat kidney diseases as treatment
neocap

General Information

Serial Number99286978
Word MarkNEOCAP
Filing DateWednesday, July 16, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, July 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations containing viral vectors for drug delivery consisting of compounds comprised of proteins in the form of capsids that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of viral capsids, viral and non viral vectors, and biodegradeable protein capsids that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of kidney disease and genetic diseases disease
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; Research and development services in the field of pharmaceutical preparations; Development of new technology for others in the field of viral vector-based gene therapy and genomic medicines to treat kidney diseases as treatment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 16, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 16, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNephrogen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events

Event DateEvent Description
Wednesday, July 16, 2025NEW APPLICATION ENTERED
Wednesday, July 16, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

neocap viral preparations pharmaceutical delivery development capsids drug kidney treatment field